This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License.

Similar documents
The cancer burden in the European Union and the European Region: the current situation and a way forward

Alcohol-related harm in Europe and the WHO policy response

Inequalities in health: challenges and opportunities in Europe Dr Zsuzsanna Jakab WHO Regional Director for Europe

Media Release. Inaugural study reveals that more than one in four women in European and Central Asian prisons locked up for drug offences

European status report on alcohol and health Leadership, awareness and commitment

European Status report on Alcohol and Health

A report on the epidemiology of selected vaccine-preventable diseases in the European Region 30% 20% 10%

Overview of drug-induced deaths in Europe - What does the data tell us?

Q1 What age are you?

WCPT COUNTRY PROFILE December 2017 SWEDEN

WCPT COUNTRY PROFILE December 2017 HUNGARY

WCPT COUNTRY PROFILE December 2017 SERBIA

Cardiovascular disease in Europe: epidemiological update 2016

Burden and cost of alcohol, tobacco and illegal drugs globally and in Europe

Highlighting in the WHO European Region: Summary. No. 21(February 2012)

WHO REGIONAL OFFICE FOR EUROPE RECOMMENDATIONS ON INFLUENZA

Highlighting in the WHO European Region: measles outbreaks rubella surveillance acute flaccid paralysis surveillance

Highlighting in the WHO European Region:

RECOMMENDATIONS ON INFLUENZA VACCINATION DURING THE WINTER SEASON

THE CVD CHALLENGE IN NORTHERN IRELAND. Together we can save lives and reduce NHS pressures

World Health Organization Regional Office for Europe Surveillance of measles and rubella Data as of 15 March 2006

Rheumatoid Arthritis Disease Burden and Access to Treatment

The health economic landscape of cancer in Europe

Smokefree Policies in Europe: Are we there yet?

Cross Border Genetic Testing for Rare Diseases

The challenge of obesity in the WHO European Region

Estimating Smoking Related Cause of Death: a Cohort Approach Based on Lung Cancer Mortality in six European Countries

Better Health for All in Latvia

Primary and secondary prevention of sudden cardiac death in emerging economies

Inequality in injury risks

Overall survival: 1 st line therapy

Table 7.1 Summary information for lung cancer in Ireland,

Where we stand in EFORT

Atherosclerotic Cardiovascular Diseases: ischaemic heart disease and stroke

Summary. Primary care data. Week 49/2014. Season

Table 9.1 Summary information for stomach cancer in Ireland,

Monthly measles and rubella monitoring report

The Current Status of Cardiac Electrophysiology in ESC Member Countries J. Brugada, P. Vardas, C. Wolpert

Cost of Disorders of the Brain in Europe Gustavsson et al. Cost of disorders of the brain in Europe Eur. Neuropsych. (2011) 21,

Table 6.1 Summary information for colorectal cancer in Ireland,

EURO POLIO PAGE Data as of 04 October 2005 (Week 38)

European Collaboration on Dementia. Luxembourg, 13 December 2006

Reflecting on ten years of progress in the fight against AIDS, TB and malaria

2016 EUROPEAN GUIDELINES ON CVD PREVENTION IN CLINICAL PRACTICE

PARALLELISM AND THE LEGITIMACY GAP 1. Appendix A. Country Information

National Institute on Alcohol Abuse and Alcoholism. Environmental Approaches

Situation update in the European Region: overview of influenza surveillance data week 40/2009 to week 07/2010.

Progress on the targets of Millennium Development Goal 6 in central and eastern Europe and central Asia

Vol. 5, No. 20 Fall 2010

Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal

Development of Palliative Care services in different countries

11 Melanoma of the skin

LEBANON. WCPT COUNTRY PROFILE December 2018

TEDDY. Teddy Network of Excellence. Annagrazia ALTAVILLA. Ph.D. Sciences Ethics LL.M. Health Law. diterranée

Secondary prevention and systems approaches: Lessons from EUROASPIRE and EUROACTION

European Association of Dental Public Health Prevention of Oral Cancer

The EHRA White Book 2009 The Current Status of Cardiac Electrophysiology in ESC Member Countries J. Brugada, P. Vardas, C. Wolpert

Drinking guidelines used in the context of early identification and brief interventions in Europe: overview of RARHA survey results

PRESS RELEASE ISSUED BY THE STATE UNIVERSITY OF NEW YORK AT ALBANY

Hypertension and Stroke: new data

DENMARK. WCPT COUNTRY PROFILE December 2018

GERMANY. WCPT COUNTRY PROFILE December 2018

Key issues for HIV testing and

Noncommunicable diseases progress monitoring. Are we meeting the time-bound United Nations targets?

Who is a migrant? 12/10/2018. HIV and migrants. Heterogeneous groups of persons with different migration drivers

Prevention of Oral Cancer Special Interest Working Group

Finnish international trade 2017 Figures and diagrams. Finnish Customs Statistics

Finnish international trade 2017 Figures and diagrams. Finnish Customs Statistics

Men & Health Work. Difference can make a difference Steve Boorman & Ian Banks RSPH Academy 2013

Where do EU Contries set the limit for low risk drinking.

CALL FOR A EUROPEAN ACTION PLAN FOR MEDICAL IMAGING TO IMPROVE QUALITY OF CARE AND PATIENT SAFETY

Monitoring noncommunicable disease commitments in Europe Theme in focus: progress monitor indicators

Positioning health equity and the social determinants of health on the regional development agenda Investment for health and development in Slovenia

Department of Biological Standardisation OMCL Network & Healthcare (DBO)

DECLARATION OF CONFLICT OF INTEREST. None

Trichinellosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods

Priorities for achieving Millennium Development Goals (MDGs) 4 and 5 in the European Region

Vol. 6, No. 21 Winter

Injuries in Europe: a call for public health action An update from 2008 WHO Global Burden of Disease

The Risk of Alcohol in Europe. Bridging the Gap June 2004

Alcohol in Europe and Brief Intervention. Dr Lars Møller Programme Manager World Health Organization Regional Office for Europe

Biology Report. Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?

Yersiniosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods. Epidemiology

The EHRA White Book 2010

Project Meeting Prague

Engagement in language assessment / Regions of Europe

Best practices in collecting and processing data in CRC screening and after it

EUDY JUNIOR CAMP 2018 FIRST ANNOUNCEMENT

Animal health situation of OIE Member Countries in Europe 1 st semester 2012 (and previous)

Underage drinking in Europe

REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS

UK bowel cancer care outcomes: A comparison with Europe

Public administration reforms and public sector performance in Central and Eastern Europe EU member states: in EU perspective

Transcription:

The State of Cardiovascular Disease in the Kyrgyz Republic Ryskul B. Kydyralieva The National Center of Cardiology and Internal Medicine named after academician M.Mirrahimov at Ministry of Health of the Kyrgyz Republic, Bishkek Vol. 2, No. 1 (2013) ISSN 2166-7403 (Online) DOI 10.5195/cajgh.2013.23 http://cajgh.pitt.edu -No Derivative Works 3.0 United States License. This site is published by the University Library System of the University of Pittsburgh as part of its D- Scribe Digital Publishing Program and is cosponsored by the University of Pittsburgh Press.

KYDYRALIEVA Keywords: Kyrgyz Republic, Cardiovascular Disease, Global Health The State of Cardiovascular Disease in the Kyrgyz Republic Ryskul B. Kydyralieva The National Center of Cardiology and Internal Medicine named after academician M.Mirrahimov at Ministry of Health of the Kyrgyz Republic, Bishkek including acute myocardial infarction), followed by cerebrovascular diseases. Figure 2: Death rate of the Kyrgyz Republic population from different cardiovascular diseases Kyrgyzstan has the sixth highest CVD mortality in Eurasia following Russia, Byelorussia, Ukraine, Kazakhstan and Moldova. It is first in the Eurasian region on the standardized parameter of mortality from stroke at 88.5 cases per 100,000. 2,3,4 Short Report According to the Republican Medical Informational Centre 1 of the Kyrgyz Republic, cardiovascular disease (CVD) was the leading cause of death in 2011, representing half (50.1 %) of all deaths. Figure 1: The structure of the reasons of death rate of the Kyrgyz Republic population (according to Republican medical and informational centre, 2011) Figure 3: Standardized death rate from cerebrovascular diseases (per 100,000 population, WHO, 2004) Figure 4: Standardized death rate from coronary heart diseases (per 100,000 population, WHO, 2004) It is especially alarming that CVD death rates are increasing among young and able-bodied people. 1,2 From 1991 to 2010, CVD mortality increased by 40.5% and 18.1 % in age categories 30-39 and 40-59, respectively. In 1991, the death rate from CVD was 261.9 (per 100,000 population), while in 2011 this reached 326.3, a 24.5% increase. More than eighteen thousand people in Kyrgyzstan die from CVD each year, over 50 every day. 1,2 The primary cause of death as related to CVD is coronary heart disease (80% of all CVD mortality, Figure 5: Death rate from cardiovascular diseases in Kyrgyzstan, ages 30-39. Figure 6: The death rate from cardiovascular diseases in Kyrgyzstan, ages 40-59.

CENTRAL ASIAN JOURNAL OF GLOBAL HEALTH CVD is not only the leading cause of death in Kyrgyz population; it causes a large percentage of premature disability. CVD accounts for 19.6% of all disability cases, exceeding similar disability parameters for other diseases. 1,2 against CVD, including institutions of local self-government, non-governmental organizations, etc. 8 Improving awareness and knowledge among family doctors, nurses, and medical assistants regarding methods to combat CVD. 9 Figure 7: Structure of premature disability of the Kyrgyz Republic population (according to Republican medical and informational centre, 1998-2011) Using estimation methods of economic efficiency, we calculated economic losses connected to cardiovascular diseases in Kyrgyzstan. Analysis revealed that economic damage from premature death and physical disability from CVD in Kyrgyzstan totaled more than 14 billions soms (around 360 million US Dollars) in 2007. 5 As reflected, the healthcare system must be reorganized to combat cardiovascular diseases and stop the deterioration of Kyrgyz health. In doing so, we may prevent serious economic and social consequences of these diseases. Taking into account the data outlined above, combating CVD in the Kyrgyz Republic is one of the key directions and priorities of national programs to reform public health. These programs, entitled "Manas Taalimi" (2006-2011) 6 and DenSooluk (2012 2016) are supported by the Government of the Kyrgyz Republic. These program implementations are performed in four key directions, including: Integrating republic-level cardiology service systems, program monitoring, and evaluation. 7 Increasing the preventive work within the general population and providing training to identify key CVD prevention principles as well as CVD treatment and complications. Empowering communities to join the fight Introducing modern technologies of diagnostics, treatment, and prevention of CVD into public health practice. Organizing public health programs to combat CVD at the Republic level will provide opportunities to lower the death rate from cardiovascular diseases, 10,11,12,13 promote significant improvement of health state of Kyrgyz people, and prolong their longevity and productivity. References 1. The public healthcare and activities of healthcare institutions of Republic of Kyrgyz. The Reports of 1999-2011. Republican Medical Information Center of Ministry of Healthcare of RK. Bishkek. 2. Kyrgyzstan in numbers. National Statistical Committee of Republic of Kyrgyzstan. Statistical reports of 2000-2011. Bishkek. 3. National report on human development. Kyrgyzstan. UNDP. Bishkek. 1997-2011. 4. The world health report, 2002. Reducing Risks, Promoting Healthy Life 5. Kydyralieva R. Scientific organizational methods of development and introduction of modern preventive and diagnostic techniques in cardiology. D.Sc. abstract. 2010. 6. National program for Healthcare Reform of Republic of Kyrgyzstan «Manas-taalimi» for 2006-2010. Bishkek. 2006: p56. 7. The World Health Report, 2008. Primary Health Care (Now More Than Ever). 8. The World Health Report, 2003. Shaping the future.

KYDYRALIEVA 9. The World Health Report, 2006. Working together for health. 10. E.I. Chazov. Cardiology in USSR. AMS of USSR. Medicine. 1982: p288. 11. Health care in Central Asia. WHO Information Center. Bishkek. 2000 12. Suhrcke M., Rosso L., McKee M. Healthcare investment: key condition for successful development of Western Europe and Central Asia. European Observatory on Health Systems and Policies. 2008: p274. 13. Adeyi O., Smith O., Robles. C. Public Policy and the Challenge of Chronic Noncommunicable Diseases. World Bank. Moscow. 2008: p187.

KYDYRALIEVA Figure 1: The structure of the reasons of death rate of the Kyrgyz Republic population (according to Republican medical and informational centre, 2011) Traumas and poisonings, 10.1% Others, 15.0% Tumors, 9.4% Infectious and parasitic diseases, 2.9% Gastrointestinal diseases, 6.8% Respiratory diseases, 7.2% Cardiovascular diseases, 50.1%

population KYDYRALIEVA Figure 2: Death rate of the Kyrgyz Republic population from different cardiovascular diseases years Cardiovascular diseases Acute myocardial infarction Coronary heart diseases Arterial hypertension

CENTRAL ASIAN JOURNAL OF GLOBAL HEALTH Figure 3: Standardized death rate from cerebrovascular diseases (per 100,000 population, WHO, 2004) SDR, cerebrovascular diseases, 0-64 per 100000, 2004 Kyrgyzstan Russian Federation Kazakhstan Republic of Moldova CIS Belarus Eur-B+C Ukraine CARK Romania Bulgaria Uzbekistan Latvia European Region Estonia Lithuania Poland EU members since May 2004 Croatia Czech Republic Slovenia Greece Finland EU Luxembourg United Kingdom Eur-A Cyprus EU members before May 2004 Germany Netherlands Spain Austria Malta Iceland 0 10 20 30 40 50 60 70 80 90

KYDYRALIEVA Figure 4: Standardized death rate from coronary heart diseases (per 100,000 population, WHO, 2004) SDR, ischaemic heart disease, 0-64 per 100000, 2004 Russian Federation Ukraine CIS Belarus Kazakhstan Eur-B+C CARK Republic of Moldova Kyrgyzstan Latvia Uzbekistan Lithuania Estonia European Region Romania Bulgaria EU members since May 2004 Poland Czech Republic Croatia Greece Finland United Kingdom EU Iceland Cyprus Malta Luxembourg Germany Slovenia Eur-A EU members before May 2004 Austria Netherlands Spain 0 50 100 150

CENTRAL ASIAN JOURNAL OF GLOBAL HEALTH Figure 5: Death rate from cardiovascular diseases in Kyrgyzstan, ages 30-39. 80 60 40 20 Cardiovas cular 1991 2005 2006 2007 2008 2009 2010 0

KYDYRALIEVA Figure 6: The death rate from cardiovascular diseases in Kyrgyzstan, ages 40-59. 400 300 200 100 Cardiovas cular 1991 2005 2006 2007 2008 2009 2010 0

% CENTRAL ASIAN JOURNAL OF GLOBAL HEALTH Figure 7: Structure of premature disability of the Kyrgyz Republic population (according to Republican medical and informational centre, 1998-2011) Cardiovascular diseases" Infectious and parasitic diseases Traumas and poisonings